These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Neuroleptic malignant syndrome in users of risperidone]. van Waarde JA; Kuiper J; Verwey B Ned Tijdschr Geneeskd; 2005 Jan; 149(3):156-7; author reply 157. PubMed ID: 15693593 [No Abstract] [Full Text] [Related]
25. Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia. Onor ML; Saina M; Trevisiol M; Cristante T; Aguglia E Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):205-9. PubMed ID: 17020789 [TBL] [Abstract][Full Text] [Related]
26. [Neuroleptic malignant syndrome in users of risperidone]. Kroon JG Ned Tijdschr Geneeskd; 2005 Jan; 149(3):157-8; author reply 158. PubMed ID: 15693594 [No Abstract] [Full Text] [Related]
27. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients. Kissling W; Glue P; Medori R; Simpson S Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187 [TBL] [Abstract][Full Text] [Related]
28. [Use of rispolept for psychotic symptoms in elderly patients with vascular psychoorganic syndrome]. Kruglov LS Voen Med Zh; 2002 May; 323(5):63-7. PubMed ID: 12073845 [No Abstract] [Full Text] [Related]
29. Early Alzheimer's disease. Mahmoud R; Greenspan A N Engl J Med; 2004 Jan; 350(1):80-2; author reply 80-2. PubMed ID: 14708129 [No Abstract] [Full Text] [Related]
30. Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials. Wooltorton E CMAJ; 2002 Nov; 167(11):1269-70. PubMed ID: 12451085 [No Abstract] [Full Text] [Related]
31. The use of antipsychotic agents in the management of behavioral disorders in the elderly with dementia: evaluating recent clinical data. Worz CR Director; 2008; 16(2):17-20. PubMed ID: 19343879 [No Abstract] [Full Text] [Related]
32. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication. Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660 [TBL] [Abstract][Full Text] [Related]
33. Increased risk of cerebrovascular adverse events and death in elderly demented patients treated with atypical antipsychotics: what's a clinician to do? Nelson JC J Clin Psychiatry; 2005 Aug; 66(8):1071. PubMed ID: 16086625 [No Abstract] [Full Text] [Related]
34. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Reilly JL; Harris MS; Keshavan MS; Sweeney JA Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499 [TBL] [Abstract][Full Text] [Related]
35. Cerebrovascular events after treatment of dementia patients with risperidone. Wancata J Int Psychogeriatr; 2004 Dec; 16(4):493-5. PubMed ID: 15715366 [No Abstract] [Full Text] [Related]
36. Antipsychotic therapy for dementia in elderly patients. Kassabian S Arch Intern Med; 2009 Jan; 169(1):87-8. PubMed ID: 19139329 [No Abstract] [Full Text] [Related]
37. Antipsychotic drugs in dementia: what should be made of the risks? Rabins PV; Lyketsos CG JAMA; 2005 Oct; 294(15):1963-5. PubMed ID: 16234504 [No Abstract] [Full Text] [Related]
38. Risperidone safety in pregnancy. A case report. RodrÃguez-Salgado B Actas Esp Psiquiatr; 2008; 36(6):366-8. PubMed ID: 18985459 [TBL] [Abstract][Full Text] [Related]